166 related articles for article (PubMed ID: 31884690)
1. A case of a primary cutaneous diffuse large B-cell lymphoma, leg type.
Marasca C; Fabbrocini G; Cinelli E; Fontanella G; Marasca D; Zagaria O
Int Wound J; 2020 Apr; 17(2):514-515. PubMed ID: 31884690
[No Abstract] [Full Text] [Related]
2. Primary cutaneous diffuse large B cell lymphoma, leg type.
Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
[No Abstract] [Full Text] [Related]
3. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
[TBL] [Abstract][Full Text] [Related]
4. Widespread primary cutaneous diffuse large B-cell lymphoma, leg type, with nasal involvement.
Bostan E; Akdogan N; Saglam Ayhan A; Ersoy Evans S
Int Wound J; 2019 Aug; 16(4):1063-1067. PubMed ID: 31099459
[No Abstract] [Full Text] [Related]
5. Intravascular large B-cell lymphoma diagnosed by incisional random skin biopsy after failure of diagnosis using punch biopsy: A case report.
Enzan N; Kitadate A; Suzuki H; Yoshioka M; Narita K; Tanaka A; Matsue K
J Cutan Pathol; 2021 Apr; 48(4):589-591. PubMed ID: 32940371
[No Abstract] [Full Text] [Related]
6. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.
Wobser M; Kneitz H; Bröcker EB; Becker JC
J Dtsch Dermatol Ges; 2011 Mar; 9(3):204-11. PubMed ID: 21122066
[TBL] [Abstract][Full Text] [Related]
7. Malignant lymphomas in the elderly.
O'Reilly SE; Connors JM; Macpherson N; Klasa R; Hoskins P
Clin Geriatr Med; 1997 May; 13(2):251-63. PubMed ID: 9115450
[TBL] [Abstract][Full Text] [Related]
8. [Rituximab in the treatment of diffuse large B-cell lymphoma: The CACNA1C subunit of channel Cav1.2 expression linked to certain forms of resistance].
Bouabdallah S; Mariko ML; Besson J; Dellis O
Med Sci (Paris); 2021 Apr; 37(4):406-408. PubMed ID: 33908862
[No Abstract] [Full Text] [Related]
9. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
Pantelaki I; Tigges C; Nußbaum T; Oellig F; Wieland U; Kreuter A
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508527
[No Abstract] [Full Text] [Related]
10. Primary cutaneous multifocal CD30+ anaplastic large cell lymphoma.
Asha LK; Thomas D; Binitha MP; Nandakumar G
Indian J Dermatol Venereol Leprol; 2006; 72(5):376-8. PubMed ID: 17050936
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification.
Aoki K; Arima H; Tabata S; Matsushita A; Ishikawa T; Takahashi T
Ann Hematol; 2012 Dec; 91(12):1975-6. PubMed ID: 22592652
[No Abstract] [Full Text] [Related]
12. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
[No Abstract] [Full Text] [Related]
13. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
[No Abstract] [Full Text] [Related]
14. DLBCL developed into fatal liver failure during rituximab-containing chemotherapy.
Shimazu Y; Nohgawa M
J Clin Exp Hematop; 2019; 59(2):93-95. PubMed ID: 31257349
[No Abstract] [Full Text] [Related]
15. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type on the Dorsal Foot in a Senior Woman: A Case Report.
Kelly J; Mirkin G; Yim J; Hao X
J Am Podiatr Med Assoc; 2022; 112(6):. PubMed ID: 36525320
[TBL] [Abstract][Full Text] [Related]
16. Ulcerated cutaneous Richter syndrome.
De Mello RB; Do Vale ECS
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054942
[TBL] [Abstract][Full Text] [Related]
17. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
[TBL] [Abstract][Full Text] [Related]
18. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
19. A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma.
Shi Y; Song Y; Qin Y; Zhang Q; Han X; Hong X; Wang D; Li W; Zhang Y; Feng J; Yang J; Zhang H; Jin C; Yang Y; Hu J; Wang Z; Jin Z; Su H; Wang H; Yang H; Fu W; Zhang M; Zhang X; Chen Y; Ke X; Liu L; Yu D; Chen G; Wang X; Jin J; Sun T; Du X; Cheng Y; Yi P; Zhao X; Ma C; Cheng J; Chai K; Luk A; Liu E; Zhang X
J Hematol Oncol; 2020 Apr; 13(1):38. PubMed ID: 32299513
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Richter Syndrome mimicking a lower limb cellulitis infection - a case report and review of the literature.
César A; Calistru A; Pardal J; Magina S; Mota A; Azevedo F
Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
